The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A
<p>Abstract</p> <p>Background</p> <p>Amifostine (WR-2721, delivered as Ethyol<sup>®</sup>) is a phosphorylated aminothiol compound clinically used in addition to cis-platinum to reduce the toxic side effects of therapeutic treatment on normal cells without r...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-03-01
|
| Series: | BMC Medicine |
| Online Access: | http://www.biomedcentral.com/1741-7015/8/19 |